Trial Profile
Evaluation of LY900014 in a Medtronic Pump
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary) ; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 25 Sep 2020 Results presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
- 16 Jun 2020 Primary endpoint (Percentage of Time with Sensor Glucose Values Between 70 and 180 Milligrams per Deciliter (mg/dL)) has not been met, according to results presented at the 80th Annual Scientific Sessions of the American Diabetes Association
- 16 Jun 2020 Results presented at the 80th Annual Scientific Sessions of the American Diabetes Association